Toggle navigation
About
About us
Management Team
Board of Directors
Advisory Board
R&D
Immuno-oncology
Technology
Collaborations
Publications
Posters
Clinical program
Partnering
Investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
News
Press releases & other news
Subscribe
Contact
post@lytixbiopharma.com
Investors |
Analyst coverage
RedEye Equity Research
Richard Ramanius
richard.ramanius@redeye.se
Click
here
to get access to Redeye's research on Lytix
Rx Securities
Joseph Hedden
joseph@rxsecurities.com
investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
